Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Pharmaceuticals›Pharmaceuticals
Pharmaceuticals · weight
3.06%
Industry change · 12M
-1.12 pp
Pharmaceuticals · contribution
-1.118 pp
Company participation
0%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Mar 2026 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
Lilly (Eli) →
LLY
United States$867.7bn1.264%-0.726 pp-0.596 pp+12.2%No
Bristol Myers Squibb →
BMY
United States$123.5bn0.180%-0.035 pp-0.114 pp+4.5%No
Pfizer →
PFE
United States$159.7bn0.233%-0.045 pp-0.108 pp+18.9%No
Merck & Co. →
MRK
United States$297.4bn0.433%-0.079 pp-0.105 pp+38.9%No
Zoetis →
ZTS
United States$49.9bn0.073%-0.036 pp-0.102 pp-27.2%No
Johnson & Johnson →
JNJ
United States$589.1bn0.858%-0.119 pp-0.090 pp+51.5%No
Viatris →
VTRS
United States$15.6bn0.023%-0.005 pp-0.002 pp+62.3%No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.